069620 — Daewoong Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩1tn
- KR₩2tn
- KR₩1tn
- 79
- 51
- 38
- 59
Annual cashflow statement for Daewoong Pharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 28,866 | 24,148 | 30,257 | 39,163 | 120,003 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 34,878 | 20,655 | 13,038 | 27,049 | 16,450 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -45,023 | 16,636 | -42,865 | 13,650 | -43,145 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 57,600 | 100,981 | 39,994 | 118,215 | 136,009 |
| Capital Expenditures | -22,314 | -26,486 | -29,088 | -65,161 | -109,338 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -63,291 | -100,665 | -58,595 | -41,710 | -56,283 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -85,605 | -127,152 | -87,683 | -106,872 | -165,621 |
| Financing Cash Flow Items | — | -4,796 | 18,740 | 25,050 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5,660 | 66,587 | 50,224 | 15,517 | 39,218 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -33,240 | 40,205 | 3,608 | 27,044 | 8,555 |